AstraZeneca's (AZN) "Hold" Rating Reaffirmed at Shore Capital
A number of other equities analysts have also weighed in on AZN. Liberum Capital reiterated a "hold" rating on shares of AstraZeneca in a report on Friday, May 18th.
from Biotech News
A number of other equities analysts have also weighed in on AZN. Liberum Capital reiterated a "hold" rating on shares of AstraZeneca in a report on Friday, May 18th.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments